Alliance for Pandemic Preparedness

April 16, 2020

Brief Report: Identifying common pharmacotherapies associated with reduced COVID-19 morbidity using electronic health records

Category:

Topic:

  • Results from a cohort study across 5 Eastern Massachusetts hospitals suggest that electronic health records may complement efforts to identify novel therapeutics for COVID-19 by identifying FDA-approved compounds with potential benefit in reducing COVID-19 associated morbidity. 
  • Preliminary findings based on a comparison of ranked electronic prescribing frequencies indicate that medications enriched among test-positive individuals not requiring hospitalization included ibuprofen, valacyclovir, and naproxen. 

Castro et al. (Apr 16, 2020). Brief Report: Identifying common pharmacotherapies associated with reduced COVID-19 morbidity using electronic health records. Pre-print downloaded Apr 16 from https://doi.org/10.1101/2020.04.11.20061994